Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 09, 2023

BUY
$1.79 - $2.9 $6,678 - $10,819
3,731 New
3,731 $9,000
Q4 2021

Feb 11, 2022

SELL
$5.97 - $7.93 $316 - $420
-53 Reduced 18.86%
228 $2,000
Q3 2021

Nov 10, 2021

SELL
$4.79 - $6.68 $17,588 - $24,528
-3,672 Reduced 92.89%
281 $2,000
Q2 2021

Aug 05, 2021

BUY
$5.35 - $6.35 $19,928 - $23,653
3,725 Added 1633.77%
3,953 $23,000
Q3 2020

Nov 10, 2020

SELL
$5.78 - $7.47 $14,473 - $18,704
-2,504 Reduced 91.65%
228 $1,000
Q2 2020

Aug 07, 2020

SELL
$4.5 - $7.02 $46,822 - $73,043
-10,405 Reduced 79.2%
2,732 $19,000
Q1 2020

May 13, 2020

BUY
$2.87 - $5.49 $36,942 - $70,667
12,872 Added 4857.36%
13,137 $61,000
Q4 2019

Feb 04, 2020

SELL
$3.84 - $4.86 $11,631 - $14,720
-3,029 Reduced 91.96%
265 $1,000
Q3 2019

Nov 08, 2019

SELL
$4.86 - $6.05 $193,588 - $240,989
-39,833 Reduced 92.36%
3,294 $17,000
Q2 2019

Aug 13, 2019

BUY
$4.51 - $6.6 $44,761 - $65,505
9,925 Added 29.89%
43,127 $242,000
Q1 2019

May 08, 2019

SELL
$5.16 - $6.85 $1,795 - $2,383
-348 Reduced 1.04%
33,202 $206,000
Q4 2018

Feb 13, 2019

BUY
$4.89 - $7.16 $34,992 - $51,236
7,156 Added 27.11%
33,550 $170,000
Q3 2018

Nov 01, 2018

SELL
$6.89 - $7.78 $11,609 - $13,109
-1,685 Reduced 6.0%
26,394 $190,000
Q2 2018

Aug 08, 2018

SELL
$5.19 - $7.25 $37,342 - $52,163
-7,195 Reduced 20.4%
28,079 $187,000
Q1 2018

May 08, 2018

SELL
$3.56 - $5.74 $8,002 - $12,903
-2,248 Reduced 5.99%
35,274 $193,000
Q4 2017

Feb 02, 2018

SELL
$2.76 - $3.95 $2,318 - $3,318
-840 Reduced 2.19%
37,522 $127,000
Q3 2017

Nov 13, 2017

BUY
$2.22 - $2.73 $85,163 - $104,728
38,362
38,362 $105,000

Others Institutions Holding CERS

About CERUS CORP


  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $312M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Us Bancorp \De\ Portfolio

Follow Us Bancorp \De\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.